Markets:

Overview

News

Currencies

International

Treasuries

Clene Inc. - Common Stock (NQ:CLNN)

5.430 +0.150 (+2.84%)

Streaming Delayed Price Updated: 1:47 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clene Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Clene Nanomedicine Announces Participation in Renmark Virtual Non-Deal Roadshow Series on January 18 and January 23

January 11, 2023

From Clene Inc.

Via GlobeNewswire

Clene's COVID-19 Candidate Shows No Substantial Symptom Resolution In Phase 2 Trial ↗

December 28, 2022

Via Benzinga

Clene Nanomedicine Reports Topline Results of Phase 2 COVID-19 Study of CNM-ZnAg

December 27, 2022

From Clene Inc.

Via GlobeNewswire

Clene Announces Closing of $5 Million Debt Facility from the State of Maryland

December 12, 2022

Funding Demonstrates Importance of Working with Private Sector to Improve Lives of Marylanders, says Governor Hogan

From Clene Inc.

Via GlobeNewswire

Recap: Clene Q2 Earnings ↗

August 15, 2022

Clene (NASDAQ:CLNN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 28, 2022

Via Benzinga

VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8® Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies

November 28, 2022

From Clene Inc.

Via GlobeNewswire

Clene: Q3 Earnings Insights ↗

November 07, 2022

Clene (NASDAQ:CLNN) reported its Q3 earnings results on Monday, November 7, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Clene beat estimated earnings by...

Via Benzinga

Clene Reports Third Quarter 2022 Financial Results and Recent Operating Highlights

November 07, 2022

From Clene Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

October 31, 2022

During Monday's session, 96 stocks hit new 52-week lows.

Via Benzinga

Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland

October 31, 2022

From Clene Inc.

Via GlobeNewswire

A Look Into Healthcare Sector Value Stocks ↗

October 24, 2022

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope ↗

October 10, 2022

People suffering from incurable neurological diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) hope new therapies and drugs will arrive sooner than later.

Via Benzinga

Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket ↗

October 05, 2022

Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 04, 2022

On Tuesday, 44 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 05, 2022

Wednesday saw 127 companies set new 52-week lows.

Via Benzinga

Domino's Pizza To $385? Plus This Analyst Cuts Price Target On Adaptimmune Therapeutics By Around 79% ↗

October 04, 2022

UBS cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $430 to $385. Domino's shares rose 4% to $329.11 on Tuesday.

Via Benzinga

October 04, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...

Via Benzinga

Nasdaq Jumps 270 Points; Silver Surges Over 8% ↗

October 03, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 03, 2022

Gainers

Via Benzinga

Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session ↗

October 03, 2022

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.

Via Benzinga

S&P 500 Surges 2%; Crude Oil Rises Sharply ↗

October 03, 2022

U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday.

Via Benzinga

US Stocks Open Higher; Dow Jumps 250 Points ↗

October 03, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 250 points on Monday.

Via Benzinga

Why Clene Shares Are Trading Sharply Lower Monday ↗

October 03, 2022

Clene Inc. (NASDAQ: CLNN) shares are trading lower by 25.90% to $2.09 during Monday's pre-market session after the company announced topline results in the Healey ALS Platform trial of CNM-Au8.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 03, 2022

Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million.

Via Benzinga

Clene Stock Falls As Lead Asset Fails To Show Survival, Function Benefit In Amyotrophic Lateral Sclerosis Trial ↗

October 03, 2022

Via Benzinga

Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial

October 03, 2022

From Clene Inc.

Via GlobeNewswire

Clene to Report HEALEY ALS Platform Trial Topline Results on Monday, October 3

September 30, 2022

Conference Call and Webcast Set for 8:30 a.m. EDT

From Clene Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 15, 2022

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Clene Inc. - Common Stock (NQ:CLNN)

All News about Clene Inc. - Common Stock

Starting at /week.